RecruitingNot Applicable

A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Children With Developmental Delays

South Korea70 participantsStarted 2026-02-05

Plain-language summary

The goal of this clinical trial is to evaluate the preliminary effectiveness and acceptability of a self-instructional, web-based teacher training program designed to support the development of autistic children and children with developmental delays. This study aims to examine whether participation in the program can improve teachers' knowledge, attitudes, and teaching self-efficacy related to inclusive education and support for autistic children and children with developmental delays. The main questions it aims to answer are: 1. Does participation in the self-instructional program improve teachers' knowledge about autism and developmental delays? 2. Does the program improve teachers' attitudes toward inclusive education and their teaching self-efficacy? Researchers will compare teachers who participate in the self-instructional online intervention program (SEED program) with teachers who receive comparison educational materials (Kit for Kids from Organization for Autism Research) to determine whether the intervention leads to greater improvements in knowledge, attitudes, and teaching self-efficacy. Participants will: 1. Complete an online pre-intervention survey assessing background information, knowledge, attitudes toward inclusion and neurodiversity, and teaching self-efficacy. 2. Participate in a two-week self-instructional online program or receive comparison materials, depending on group assignment 3. Complete an online post-intervention survey evaluating the same outcomes, as well as program satisfaction and acceptability.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Public school teachers currently employed in kindergarten or elementary schools who hold at least a Level 2 teaching certificate (or higher). * Teachers who understand the purpose of the study and provide informed consent to participate. Exclusion Criteria: * Teachers who have majored in special education at the undergraduate or graduate level.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

(Knowledge) Autism Knowledge Questionnaire-2 (ASK-Q-2) Total Score

Timeframe: Baseline (pre-intervention) and immediately after the intervention

(Knowledge) Participatory Autism Knowledge Measure (PAK-M) Total Score

Timeframe: Baseline (pre-intervention) and immediately after the intervention

(Knowledge) Survey for Educators' Empowerment for Diversity (SEED) Total Score

Timeframe: Baseline (pre-intervention) and immediately after the intervention

(Attitude) Teacher Attitudes Toward Inclusion Scale (TATIS) Total Score

Timeframe: Baseline (pre-intervention) and immediately after the intervention

(Attitude) Neurodiversity Attitudes Questionnaire (NDAQ) Total Score

Timeframe: Baseline (pre-intervention) and immediately after the intervention

(Attitude) Sentiments, Attitudes, and Concerns about Inclusive Education - Revised (SACIE-R) Total Score

Timeframe: Baseline (pre-intervention) and immediately after the intervention

Trial details

NCT IDNCT07524192

SponsorBoin Choi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-30

Contact for this trial

Boin Choi

+82-10-5077-0345 boinchoi@ewha.ac.kr

View on ClinicalTrials.gov More Autism Spectrum Disorder trials